137 related articles for article (PubMed ID: 36541237)
1. The clinical phenotype of primary Sjögren's syndrome patients with lymphadenopathy.
Stergiou IE; Chatzis LG; Pezoulas VC; Baldini C; Fotiadis DI; Voulgarelis M; Tzioufas AG; Goules AV
Clin Exp Rheumatol; 2022 Dec; 40(12):2357-2362. PubMed ID: 36541237
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory findings of primary Sjögren's syndrome patients without sicca symptoms.
Chatzis LG; Koulouri V; Baldini C; Pezoulas VC; Voulgari PV; Skopouli FN; Fotiadis DI; Tzioufas AG; Goules AV
Clin Exp Rheumatol; 2022 Dec; 40(12):2298-2302. PubMed ID: 36200933
[TBL] [Abstract][Full Text] [Related]
3. Lower frequency of focal lip sialadenitis (focus score) in smoking patients. Can tobacco diminish the salivary gland involvement as judged by histological examination and anti-SSA/Ro and anti-SSB/La antibodies in Sjögren's syndrome?
Manthorpe R; Benoni C; Jacobsson L; Kirtava Z; Larsson A; Liedholm R; Nyhagen C; Tabery H; Theander E
Ann Rheum Dis; 2000 Jan; 59(1):54-60. PubMed ID: 10627428
[TBL] [Abstract][Full Text] [Related]
4. Combined seronegativity in Sjögren's syndrome.
Chatzis LG; Pezoulas V; Voulgari PV; Baldini C; Exarchos TP; Fotiadis DI; Mavragani CP; Skopouli FN; Moutsopoulos HM; Tzioufas AG; Goules AV
Clin Exp Rheumatol; 2021; 39 Suppl 133(6):80-84. PubMed ID: 34665703
[TBL] [Abstract][Full Text] [Related]
5. Primary Sjögren's Syndrome of Early and Late Onset: Distinct Clinical Phenotypes and Lymphoma Development.
Goules AV; Argyropoulou OD; Pezoulas VC; Chatzis L; Critselis E; Gandolfo S; Ferro F; Binutti M; Donati V; Zandonella Callegher S; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos T; Mavragani CP; Baldini C; Skopouli FN; Fotiadis DI; De Vita S; Moutsopoulos HM; Tzioufas AG
Front Immunol; 2020; 11():594096. PubMed ID: 33193443
[TBL] [Abstract][Full Text] [Related]
6. Significance of anti-La/SSB antibodies in primary Sjögren's syndrome patients with combined positivity for anti-Ro/SSA and salivary gland biopsy.
Cafaro G; Perricone C; Baldini C; Quartuccio L; Priori R; Carubbi F; Ferro F; Colafrancesco S; Bini V; De Vita S; Giacomelli R; Gerli R; Bartoloni E;
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):53-56. PubMed ID: 33095137
[TBL] [Abstract][Full Text] [Related]
7. Overlap of ACA-positive systemic sclerosis and Sjögren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma.
Baldini C; Mosca M; Della Rossa A; Pepe P; Notarstefano C; Ferro F; Luciano N; Talarico R; Tani C; Tavoni AG; Bombardieri S
Clin Exp Rheumatol; 2013; 31(2):272-80. PubMed ID: 23343785
[TBL] [Abstract][Full Text] [Related]
8. Anti-SSA/SSB-negative Sjögren's syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution.
Quartuccio L; Baldini C; Bartoloni E; Priori R; Carubbi F; Corazza L; Alunno A; Colafrancesco S; Luciano N; Giacomelli R; Gerli R; Valesini G; Bombardieri S; De Vita S
Autoimmun Rev; 2015 Nov; 14(11):1019-22. PubMed ID: 26162302
[TBL] [Abstract][Full Text] [Related]
9. The value of separate detection of anti-Ro52, anti-Ro60 and anti-SSB/La reactivities in relation to diagnosis and phenotypes in primary Sjögren's syndrome.
Deroo L; Achten H; De Boeck K; Genbrugge E; Bauters W; Roels D; Dochy F; Creytens D; Deprez J; Van den Bosch F; Elewaut D; Peene I
Clin Exp Rheumatol; 2022 Dec; 40(12):2310-1317. PubMed ID: 36200940
[TBL] [Abstract][Full Text] [Related]
10. Long-term follow-up in primary Sjögren's syndrome reveals differences in clinical presentation between female and male patients.
Ramírez Sepúlveda JI; Kvarnström M; Eriksson P; Mandl T; Norheim KB; Johnsen SJ; Hammenfors D; Jonsson MV; Skarstein K; Brun JG; ; Rönnblom L; Forsblad-d'Elia H; Magnusson Bucher S; Baecklund E; Theander E; Omdal R; Jonsson R; Nordmark G; Wahren-Herlenius M
Biol Sex Differ; 2017 Aug; 8(1):25. PubMed ID: 28789696
[TBL] [Abstract][Full Text] [Related]
11. Systemic phenotype related to primary Sjögren's syndrome in 279 patients carrying isolated anti-La/SSB antibodies.
Acar-Denizli N; Horváth IF; Mandl T; Priori R; Vissink A; Hernandez-Molina G; Armagan B; Praprotnik S; Sebastian A; Bartoloni E; Rischmueller M; Pasoto SG; Nordmark G; Nakamura H; Fernandes Moça Trevisani V; Retamozo S; Carsons SE; Maure-Noia B; Sánchez-Berná I; López-Dupla M; Fonseca-Aizpuru E; Melchor Díaz S; Vázquez M; Díaz Cuiza PE; de Miguel Campo B; Ng WF; Rasmussen A; Dong X; Li X; Baldini C; Seror R; Gottenberg JE; Kruize AA; Sandhya P; Gandolfo S; Kwok SK; Kvarnstrom M; Solans R; Sene D; Suzuki Y; Isenberg DA; Valim V; Hofauer B; Giacomelli R; Devauchelle-Pensec V; Atzeni F; Gheita TA; Morel J; Izzo R; Kalyoncu U; Szántó A; Olsson P; Bootsma H; Ramos-Casals M; Kostov B; Brito-Zerón P;
Clin Exp Rheumatol; 2020; 38 Suppl 126(4):85-94. PubMed ID: 33095152
[TBL] [Abstract][Full Text] [Related]
12. [Comparison of clinical and immunological characteristics between primary Sjögren's syndrome patients with positive and negative anti-SSB antibody].
Han YJ; Li CH; Chen XY; Zhao JX
Beijing Da Xue Xue Bao Yi Xue Ban; 2023 Dec; 55(6):1000-1006. PubMed ID: 38101780
[TBL] [Abstract][Full Text] [Related]
13. Serological profiles in subgroups of patients with Sjögren's syndrome.
Manoussakis MN; Tzioufas AG; Pange PJ; Moutsopoulos HM
Scand J Rheumatol Suppl; 1986; 61():89-92. PubMed ID: 3473654
[TBL] [Abstract][Full Text] [Related]
14. [The relationship between Sjogren's syndrome, systemic sclerosis and lymphoproliferative diseases].
Vasil'ev VI; Chal'tsev BD; Gorodetskii VR; Pal'shina SG; Shornikova NS; Anan'eva LP; Gaiduk IV; Kokosadze NV; Probatova NA; Pavlovskaia AI; Rodionova EB; Safonova TN; Balabina AA
Ter Arkh; 2020 Dec; 92(12):126-136. PubMed ID: 33720584
[TBL] [Abstract][Full Text] [Related]
15. Sjögren's syndrome with and without neurological involvement.
Seeliger T; Kramer E; Konen FF; Zehrfeld N; Beider S; Prenzler NK; Gödecke V; Witte T; Skripuletz T; Ernst D
J Neurol; 2023 Jun; 270(6):2987-2996. PubMed ID: 36802030
[TBL] [Abstract][Full Text] [Related]
16. Glandular involvement in primary Sjögren's syndrome patients with interstitial lung disease-onset and sicca-onset, a single centre cross-sectional study.
La Rocca G; Ferro F; Bulleri A; Fulvio G; Fonzetti S; Donati V; Romei C; Mosca M; Baldini C
Clin Exp Rheumatol; 2022 Dec; 40(12):2344-2349. PubMed ID: 36533977
[TBL] [Abstract][Full Text] [Related]
17. A lower prevalence of malignant lymphoma in Sjögren's syndrome patients: A cross-sectional study.
Saleh W; Elashry MM; Winn N; Mona M; Katz J; Cha S
Oral Dis; 2023 Nov; 29(8):3313-3324. PubMed ID: 36369668
[TBL] [Abstract][Full Text] [Related]
18. Cryoglobulinemic vasculitis in primary Sjögren's Syndrome: Clinical presentation, association with lymphoma and comparison with Hepatitis C-related disease.
Argyropoulou OD; Pezoulas V; Chatzis L; Critselis E; Gandolfo S; Ferro F; Quartuccio L; Donati V; Treppo E; Bassoli CR; Venetsanopoulou A; Zampeli E; Mavrommati M; Voulgari PV; Exarchos TE; Mavragani CP; Baldini C; Skopouli FN; Galli M; Fotiadis DΙ; De Vita S; Moutsopoulos HM; Tzioufas AG; Goules AV
Semin Arthritis Rheum; 2020 Oct; 50(5):846-853. PubMed ID: 32896698
[TBL] [Abstract][Full Text] [Related]
19. Artificial neural networks help to identify disease subsets and to predict lymphoma in primary Sjögren's syndrome.
Baldini C; Ferro F; Luciano N; Bombardieri S; Grossi E
Clin Exp Rheumatol; 2018; 36 Suppl 112(3):137-144. PubMed ID: 30156549
[TBL] [Abstract][Full Text] [Related]
20. Differences in clinical phenotypes of primary Sjögren's syndrome depending on early or late onset.
Sebastian A; Madej M; Sebastian M; Morgiel E; Wawryka P; Wiland P
Adv Clin Exp Med; 2021 Nov; 30(11):1141-1146. PubMed ID: 34549557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
